eCARTv5 Clinical Deterioration Suite (“eCART”) vs University of Birmingham

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
eCARTv5 Clinical Deterioration Suite (“eCART”)
by AgileMD
VS
University of Birmingham
by University of Birmingham

AI Verdict

Both tools offer clinical decision support integrated with EHRs, making them comparable in their general aim to assist clinicians. However, AgileMD's eCARTv5 is an FDA-cleared, AI-powered Software as a Medical Device specifically focused on predicting clinical deterioration and guiding care with pathways, while the University of Birmingham's AI Consult is a large language model-based tool providing broader diagnostic and treatment suggestions. Therefore, eCARTv5 is better suited for critical care and early warning systems, whereas AI Consult might be more broadly applicable for general diagnostic and treatment assistance.

Choose eCARTv5 Clinical Deterioration Suite (“eCART”) if…

Choose eCARTv5 Clinical Deterioration Suite if your primary need is an FDA-cleared, AI-powered solution for continuous, real-time prediction of clinical deterioration (death or ICU transfer) in hospitalized adult patients. This tool is ideal for hospitals seeking to proactively identify at-risk patients, reduce false alarms, and guide care with embedded clinical pathways, ultimately aiming to improve patient outcomes and operational efficiency in critical care, emergency medicine, and hospital medicine settings.

View eCARTv5 Clinical Deterioration Suite (“eCART”) →

Choose University of Birmingham if…

Choose AI Consult from the University of Birmingham if you are looking for a large language model-based clinical decision support tool embedded within an electronic medical record system to provide real-time diagnostic and treatment suggestions. This tool is best suited for healthcare providers in specialties like Family Medicine, Hospital Medicine, and Internal Medicine who need immediate, AI-driven insights to assist with diagnosis and treatment planning directly within their existing EMR workflow.

View University of Birmingham →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature eCARTv5 Clinical Deterioration Suite (“eCART”) University of Birmingham
Pricing Contact vendor for tailored quote. N/a
Deployment Cloud-based SaaS, integrated directly into Electronic Health Record (EHR) systems. N/A
FDA Status 1 AI-estimated N/a

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

eCARTv5 Clinical Deterioration Suite (“eCART”)

AgileMD's eCARTv5 is designed for seamless integration with existing EHR systems, aiming to streamline workflows and minimize false alarms, which directly contributes to better usability for clinicians. User reviews highlight its intuitive interface and real-time insights as key strengths. In contrast, while the University of Birmingham's AI Consult is embedded within EMR, there is less specific information available regarding its user interface design or explicit claims about minimizing clinician workload.

Clinical Value

eCARTv5 Clinical Deterioration Suite (“eCART”)

AgileMD's eCARTv5 has demonstrated strong clinical value through extensive validation, showing it can predict clinical deterioration hours before critical illness, reduce false alarms, and guide care with embedded clinical pathways. It has been validated on nearly 3 million patient encounters across 28 hospitals. The University of Birmingham's AI Consult, while improving the quality of clinical decision-making, did not significantly change short-term patient outcomes in a large real-world trial.

Pricing & Value

eCARTv5 Clinical Deterioration Suite (“eCART”)

AgileMD's eCARTv5, as a commercial product, offers clear pricing by vendor contact for tailored quotes, indicating a defined value proposition for healthcare organizations. The University of Birmingham's AI Consult, being a university project, has no applicable product pricing, making a direct comparison of value difficult in a commercial context.

Enterprise Readiness

eCARTv5 Clinical Deterioration Suite (“eCART”)

AgileMD's eCARTv5 is an FDA-cleared Software as a Medical Device (SaMD) with HIPAA compliance and BAA availability, indicating its readiness for enterprise-level deployment in healthcare systems. Its cloud-based SaaS deployment model and integration with EHRs further support its enterprise readiness. The University of Birmingham's AI Consult, while embedded in EMRs for trials, lacks explicit information on regulatory clearances, broader compliance, or a commercial deployment model, suggesting it is not yet enterprise-ready as a commercial product.

Innovation

eCARTv5 Clinical Deterioration Suite (“eCART”)

AgileMD's eCARTv5 utilizes a gradient-boosted machine learning model trained on a multi-center dataset of over 800,000 patient records, analyzing up to 97 variables for continuous risk assessment. This represents a sophisticated application of AI for early warning systems. The University of Birmingham's AI Consult is innovative as a large language model-based clinical decision support tool, but the novelty of its core AI approach in this specific application is less clearly articulated compared to eCARTv5's advanced predictive modeling.

Support & Docs

eCARTv5 Clinical Deterioration Suite (“eCART”)

AgileMD offers comprehensive support services including email, phone, chat, FAQ, help desk, knowledge base, and 24/7 live support, along with documentation, in-person, live online, videos, and webinars for training. This indicates a robust support structure for a commercial product. For the University of Birmingham's AI Consult, as a research project, there is no information available regarding ongoing support or documentation for external users.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature eCARTv5 Clinical Deterioration Suite (“eCART”) University of Birmingham
Tool Name eCARTv5 Clinical Deterioration Suite (u201ceCARTu201d) AI Consult
Company AgileMD University of Birmingham
Description FDA-cleared, AI-powered Software as a Medical Device (SaMD) that integrates with EHRs to continuously assess and predict the risk of clinical deterioration (death or ICU transfer) in hospitalized adult patients, guiding care with embedded clinical pathways. A large language model-based clinical decision support tool embedded within an electronic medical record system, providing real-time diagnostic and treatment suggestions.
Key Feature 1 AI-powered clinical deterioration prediction Large language model-based
Key Feature 2 Continuous patient risk assessment (death or ICU transfer) Clinical decision support
Key Feature 3 EHR integration with real-time data (up to 97 variables) Real-time suggestions
Key Feature 4 Embedded clinical pathways for care guidance Embedded within EMR

Videos

Demos, reviews, and walkthroughs featuring eCARTv5 Clinical Deterioration Suite (“eCART”) and University of Birmingham.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

eCARTv5 is designed for seamless EHR integration, analyzing up to 97 real-time variables from the EHR to provide continuous patient risk assessment and guide care with embedded clinical pathways. AI Consult is also embedded within the EMR system, working in the background to analyze clinician-entered information and generate real-time diagnostic and treatment suggestions.
eCARTv5 has demonstrated high accuracy in predicting clinical deterioration (death or ICU transfer), outperforming other early warning systems like NEWS and MEWS in retrospective and prospective validations across diverse patient subgroups. It has a positive predictive value (PPV) of 17.3% at comparable sensitivities around 50%, nearly double that of NEWS. AI Consult, in a large real-world trial, was found to be safe and improved the quality of clinical decision-making, though it did not significantly change short-term patient outcomes.
eCARTv5 is designed with a highly intuitive user interface and well-tested clinical workflow to minimize clinician workload and facilitate adoption. AgileMD offers rapid and seamless implementation, deploying at scale in days to weeks, and provides reporting and benchmarking capabilities. For AI Consult, the University of Birmingham emphasizes supporting staff to use generative AI tools effectively and appropriately, with resources and guidance provided at the School level.
AgileMD's eCARTv5 includes advanced audit logging and monitoring services to track system activity. For AI Consult, while not explicitly detailed, the University of Birmingham's research on medical algorithmic audits suggests a framework for assessing AI technologies within real-life health and care pathways, which would involve tracking performance and potential errors.
eCARTv5 has been validated through extensive clinical performance data from nearly two million hospitalizations across 21 hospitals, ensuring consistent accuracy across diverse patient demographics and medical conditions. AgileMD supports deployment at scale in days to weeks. For AI Consult, the University of Birmingham acknowledges that AI is highly sensitive to changes in context and that its reliability in new settings or across different demographic groups is a concern that needs to be resolved.
eCARTv5 is specifically designed for hospitalized adult patients on medical-surgical wards to continuously assess and predict the risk of clinical deterioration (death or ICU transfer), providing early warnings and guiding care with clinical pathways. It is applicable across various medical conditions, including sepsis, COPD, CHF, and COVID-19. AI Consult is a general clinical decision support tool providing real-time diagnostic and treatment suggestions, with a trial conducted in primary care clinics.

More Comparisons

eCARTv5 Clinical Deterioration Suite (“eCART”) vs Google Med-PaLM 2
ChatGPT vs Google Med-PaLM 2
When choosing between ChatGPT and Google Med-PaLM 2, physicians should consider their primary use case and desired level of medical…
Brainomix 360 e-CTA vs Google Med-PaLM 2
DeepXray vs Google Med-PaLM 2

More matchups featuring eCARTv5 Clinical Deterioration Suite (“eCART”) or University of Birmingham

AI Tool Finder
AI-powered search. Results may not be comprehensive.